Business News
Novavax COVID shot is approved by FDA advisers, raising the possibility of a fourth US vaccine option
[ad_1]
Next, the FDA must decide whether to authorize the protein vaccine made by Latecomer Novavax as the nation’s fourth coronavirus shot for adults. Read More
[ad_2]
Source link
